135 related articles for article (PubMed ID: 29522880)
1. Systematically integrated metabonomic-proteomic studies of Escherichia coli under ciprofloxacin stress.
Li W; Zhang S; Wang X; Yu J; Li Z; Lin W; Lin X
J Proteomics; 2018 May; 179():61-70. PubMed ID: 29522880
[TBL] [Abstract][Full Text] [Related]
2. An integrated quantitative proteomic and metabolomics approach to reveal the negative regulation mechanism of LamB in antibiotics resistance.
Li W; Wang G; Zhang S; Fu Y; Jiang Y; Yang X; Lin X
J Proteomics; 2019 Mar; 194():148-159. PubMed ID: 30521976
[TBL] [Abstract][Full Text] [Related]
3. Comparative metabolomics shows the metabolic profiles fluctuate in multi-drug resistant Escherichia coli strains.
Lin Y; Li W; Sun L; Lin Z; Jiang Y; Ling Y; Lin X
J Proteomics; 2019 Sep; 207():103468. PubMed ID: 31374362
[TBL] [Abstract][Full Text] [Related]
4. Bacterial Argonaute Proteins Aid Cell Division in the Presence of Topoisomerase Inhibitors in Escherichia coli.
Olina A; Agapov A; Yudin D; Sutormin D; Galivondzhyan A; Kuzmenko A; Severinov K; Aravin AA; Kulbachinskiy A
Microbiol Spectr; 2023 Jun; 11(3):e0414622. PubMed ID: 37102866
[TBL] [Abstract][Full Text] [Related]
5. Proteomic comparison of three clinical diarrhoeagenic drug-resistant Escherichia coli isolates grown on CHROMagar™STEC media.
Kalule JB; Fortuin S; Calder B; Robberts L; Keddy KH; Nel AJM; Garnett S; Nicol M; Warner DF; Soares NC; Blackburn JM
J Proteomics; 2018 May; 180():25-35. PubMed ID: 28887208
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Biosynthesis of Fatty Acids Is Associated with the Acquisition of Ciprofloxacin Resistance in Edwardsiella tarda.
Su YB; Kuang SF; Ye JZ; Tao JJ; Li H; Peng XX; Peng B
mSystems; 2021 Aug; 6(4):e0069421. PubMed ID: 34427511
[TBL] [Abstract][Full Text] [Related]
8. Integrative proteomics and metabolomics approach to elucidate the antimicrobial effect of simvastatin on Escherichia coli.
Kocak E; Nemutlu E; Kır S; Sagıroglu M; Özkul C
Biomed Chromatogr; 2021 Oct; 35(10):e5180. PubMed ID: 34043824
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis.
Jin M; Lu J; Chen Z; Nguyen SH; Mao L; Li J; Yuan Z; Guo J
Environ Int; 2018 Nov; 120():421-430. PubMed ID: 30125859
[TBL] [Abstract][Full Text] [Related]
10. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
Vinué L; Corcoran MA; Hooper DC; Jacoby GA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Cefotaxime- and Ciprofloxacin-Resistant Commensal Escherichia coli Originating from Belgian Farm Animals Indicates High Antibiotic Resistance Transfer Rates.
Lambrecht E; Van Meervenne E; Boon N; Van de Wiele T; Wattiau P; Herman L; Heyndrickx M; Van Coillie E
Microb Drug Resist; 2018; 24(6):707-717. PubMed ID: 29148895
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SOS genes in ciprofloxacin resistant Escherichia coli mutants.
Pourahmad Jaktaji R; Pasand S
Gene; 2016 Jan; 576(1 Pt 1):115-8. PubMed ID: 26432001
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteome analysis of an antibiotic resistant Escherichia coli exposed to tetracycline reveals multiple affected metabolic and peptidoglycan processes.
Jones-Dias D; Carvalho AS; Moura IB; Manageiro V; Igrejas G; Caniça M; Matthiesen R
J Proteomics; 2017 Mar; 156():20-28. PubMed ID: 28043878
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
15. Proteomics for Drug Resistance on the Food Chain? Multidrug-Resistant Escherichia coli Proteomes from Slaughtered Pigs.
Ramos S; Silva N; Hébraud M; Santos HM; Nunes-Miranda JD; Pinto L; Pereira JE; Capelo JL; Poeta P; Igrejas G
OMICS; 2016 Jun; 20(6):362-74. PubMed ID: 27310477
[TBL] [Abstract][Full Text] [Related]
16. Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli.
Jerman B; Butala M; Zgur-Bertok D
Antimicrob Agents Chemother; 2005 Jul; 49(7):3087-90. PubMed ID: 15980407
[TBL] [Abstract][Full Text] [Related]
17. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
18. Biosorption behavior and proteomic analysis of Escherichia coli P4 under cadmium stress.
Khan Z; Rehman A; Nisar MA; Zafar S; Zerr I
Chemosphere; 2017 May; 174():136-147. PubMed ID: 28161514
[TBL] [Abstract][Full Text] [Related]
19. Improved Sample Preparation for Untargeted Metabolomics Profiling of Escherichia coli.
Ye D; Li X; Wang C; Liu S; Zhao L; Du J; Xu J; Li J; Tian L; Xia X
Microbiol Spectr; 2021 Oct; 9(2):e0062521. PubMed ID: 34612668
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli.
López E; Elez M; Matic I; Blázquez J
Mol Microbiol; 2007 Apr; 64(1):83-93. PubMed ID: 17376074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
